Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionWalleye Capital LLC
Latest Disclosed Ownership15,399 shares
Latest Disclosed Value $ 222,670
Walleye Capital LLC ownership in FOLD / Amicus Therapeutics, Inc.

On May 13, 2026 - Walleye Capital LLC filed a 13F-HR/A form disclosing ownership of 15,399 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $222,670 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 26,030 shares of Amicus Therapeutics, Inc.. This represents a change in shares of -40.84% during the quarter. The current value of the position is $223,132 USD.

Walleye Capital LLC has a history of taking positions in derivatives of the underlying security (FOLD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

FOLD / Amicus Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 AMICUS THERAPEUTIC COM 03152W109 15,399 -10,631 -40.84 223 -40.00 0.0009
2026-05-08 2026-03-31 13F AMICUS THERAPEUTIC COM 03152W109 15,399 -10,631 223 0.0009
2026-02-13 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 26,030 -480,831 -94.86 371 -90.74 0.0011
2025-11-14 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 506,861 470,443 1,291.79 3,994 1,820.19 0.0150
2025-08-13 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 36,418 36,418 209 0.0008
2025-05-14 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -44,516 -100.00 0 -100.00
2025-02-13 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 44,516 -359,725 -88.99 419 -90.29 0.0010
2024-11-14 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 404,241 392,630 3,381.53 4,317 3,653.91 0.0090
2024-08-14 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 11,611 -10,733 -48.04 115 -56.27 0.0002
2024-05-15 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 22,344 22,344 263 0.0005
2024-02-14 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -172,169 -100.00 0 -100.00
2023-11-21 2023-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 172,169 172,169 2,094 0.0054
2023-11-14 2023-09-30 13F AMICUS THERAPEUTICS COM 03152W109 172,169 172,169 2,094 0.0054
2022-05-27 2022-03-31 13F/A-01 AMICUS THERAPEUTICS COM 03152W109 0 -14,051 -100.00 0 -100.00
2022-05-16 2022-03-31 13F AMICUS THERAPEUTICS COM 03152W109 0 -14,051 0
2022-05-27 2021-12-31 13F/A-01 AMICUS THERAPEUTICS COM 03152W109 14,051 14,051 162 0.0050
2022-03-03 2021-12-31 13F AMICUS THERAPEUTICS COM 03152W109 14,051 14,051 162 0.0040
2021-08-16 2021-06-30 13F AMICUS THERAPEUTICS COM 03152W109 0 -33,600 -100.00 0 -100.00
2021-05-17 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 33,600 33,600 332 0.0192
2019-08-14 2019-06-30 13F AMICUS THERAPEUTICS COM 03152W109 0 -414 -100.00 0 -100.00
2019-08-14 2019-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 414 414 6 0.0010
2019-05-15 2019-03-31 13F AMICUS THERAPEUTICS COM 03152W109 414 6 0.0010
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A AMICUS THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-05-08 2026-03-31 13F AMICUS THERAPEUTICS COM Call 0 0 n/a n/a n/a
2026-02-13 2025-12-31 13F AMICUS THERAPEUTICS COM Call 100 -98.39 1 -97.92 n/a n/a n/a
2025-11-14 2025-09-30 13F AMICUS THERAPEUTICS COM Call 6,200 -88.73 49 -84.76 n/a n/a n/a
2025-08-13 2025-06-30 13F AMICUS THERAPEUTICS COM Call 55,000 315 n/a n/a n/a
2025-05-14 2025-03-31 13F AMICUS THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-13 2024-12-31 13F AMICUS THERAPEUTICS COM Call 18,000 -69.28 170 -72.96 n/a n/a n/a
2024-11-14 2024-09-30 13F AMICUS THERAPEUTICS COM Call 58,600 761.76 626 832.84 n/a n/a n/a
2024-08-14 2024-06-30 13F AMICUS THERAPEUTICS COM Call 6,800 -57.50 67 -64.36 n/a n/a n/a
2024-05-15 2024-03-31 13F AMICUS THERAPEUTICS COM Call 16,000 188 n/a n/a n/a
2024-02-14 2023-12-31 13F AMICUS THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-21 2023-09-30 13F/A AMICUS THERAPEUTICS COM Call 5,600 68 n/a n/a n/a
2023-11-14 2023-09-30 13F AMICUS THERAPEUTICS COM Call 5,600 68 n/a n/a n/a
2019-11-14 2019-09-30 13F AMICUS THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-06-30 13F AMICUS THERAPEUTICS COM Call 8,000 -18.37 100 -24.81 n/a n/a n/a
2019-08-14 2019-03-31 13F/A AMICUS THERAPEUTICS COM Call 9,800 133 n/a n/a n/a
2019-05-15 2019-03-31 13F AMICUS THERAPEUTICS COM Call 9,800 133 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A AMICUS THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2026-05-08 2026-03-31 13F AMICUS THERAPEUTICS COM Put 0 0 n/a n/a n/a
2026-02-13 2025-12-31 13F AMICUS THERAPEUTICS COM Put 5,500 -75.11 78 -55.17 n/a n/a n/a
2025-11-14 2025-09-30 13F AMICUS THERAPEUTICS COM Put 22,100 45.39 174 100.00 n/a n/a n/a
2025-08-13 2025-06-30 13F AMICUS THERAPEUTICS COM Put 15,200 87 n/a n/a n/a
2025-05-14 2025-03-31 13F AMICUS THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-13 2024-12-31 13F AMICUS THERAPEUTICS COM Put 18,600 -46.24 175 -52.57 n/a n/a n/a
2024-11-14 2024-09-30 13F AMICUS THERAPEUTICS COM Put 34,600 121.79 370 139.61 n/a n/a n/a
2024-08-14 2024-06-30 13F AMICUS THERAPEUTICS COM Put 15,600 7.59 155 -9.41 n/a n/a n/a
2024-05-15 2024-03-31 13F AMICUS THERAPEUTICS COM Put 14,500 171 n/a n/a n/a
2024-02-14 2023-12-31 13F AMICUS THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-21 2023-09-30 13F/A AMICUS THERAPEUTICS COM Put 600 7 n/a n/a n/a
2023-11-14 2023-09-30 13F AMICUS THERAPEUTICS COM Put 600 7 n/a n/a n/a
2019-11-14 2019-09-30 13F AMICUS THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-14 2019-06-30 13F AMICUS THERAPEUTICS COM Put 2,400 -73.03 30 -75.21 n/a n/a n/a
2019-08-14 2019-03-31 13F/A AMICUS THERAPEUTICS COM Put 8,900 121 n/a n/a n/a
2019-05-15 2019-03-31 13F AMICUS THERAPEUTICS COM Put 8,900 121 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.